Join the Zoloft group to help and get support from people like you.
Zoloft News
Antidepressants Linked To Sudden Cardiac Death
FRIDAY, April 4, 2025 – Antidepressants appear to increase people’s risk of sudden cardiac death, a new study says. People taking the mood meds are more likely to die suddenly from heart problems, a...
Antidepressant Use May Speed Up Cognitive Decline in Patients With Dementia
WEDNESDAY, March 5, 2025 – Current antidepressant use is associated with faster cognitive decline in patients with dementia, according to a study published online Feb. 25 in BMC Medicine. Minjia Mo,...
Antidepressants Might Accelerate Dementia Decline
TUESDAY, Feb. 25, 2025 (HealthDay news) – Antidepressants are frequently prescribed to people with dementia for symptoms like anxiety, depression, aggressiveness and sleeplessness. But a specific...
Prenatal SSRI Exposure Linked to Functional Constipation in Offspring
FRIDAY, Dec. 13, 2024 – Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of functional constipation developing in offspring, according to a...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...
FDA Medwatch Alert: Zoloft (sertraline)
[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...
FDA Medwatch Alert: Zoloft (sertraline hydrochloride)
At the request of the FDA, Pfizer issued an important drug warning letter announcing that they have added new information to the CONTRAINDICATIONS and PRECAUTIONS sections of the Zoloft labeling,...
FDA Medwatch Alert: Antidepressant Medication Products
[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitors (SSRIs) - Serotonin Syndrome
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...
FDA Medwatch Alert: SSRIs and Treatment Challenges of Depression in Pregnancy
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women...
FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults
The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening...
FDA Medwatch Alert: Public Health Advisory - Suicidality in Pediatric Patients Treated with Antidepressants for Major Depressive Disorder
The FDA notified healthcare professionals of reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric...
Further information
Related condition support groups
Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Depression, Post Traumatic Stress Disorder, Postpartum Depression, Premenstrual Dysphoric Disorder, Social Anxiety Disorder